
COVID-19
From Bench to Bedside
- 222 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
The COVID-19 pandemic has affected the entire world in an unprecedented way, and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-CoV-2 drug strategies, including repurposing drugs used for other indications and the development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials.
Key Features
- Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic
- Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management
Trusted by 375,005 students
Access to over 1 million titles for a fair monthly price.
Study more efficiently using our study tools.
Information
Table of contents
- Cover Page
- Half Title Page
- Title Page
- Copyright Page
- Dedication
- Contents
- Preface
- Acknowledgements
- Editors
- Contributors
- Chapter 1 Coronavirus Epidemics and the Current COVID-19 Pandemic
- Chapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2
- Chapter 3 Therapeutic Challenges in COVID-19
- Chapter 4 Prevention and Control Strategies for the COVID-19 Pandemic
- Chapter 5 Global Focus and Interdisciplinary Approaches in COVID-19 Research and Their Outcomes
- Chapter 6 The Evolution of COVID-19 Diagnostics
- Chapter 7 Drug Repurposing and Novel Antiviral Drugs for COVID-19 Management
- Chapter 8 Convalescent Plasma and Antibody Therapy in COVID-19
- Chapter 9 Application of Stem Cell and Exosome-Based Therapy in COVID-19
- Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19
- Chapter 11 Computational Biology and Bioinformatics in Anti-SARS-CoV-2 Drug Development
- Chapter 12 Nanomaterials in COVID-19 Drug Development
- Chapter 13 Vaccine Development Strategies and the Current Status of COVID-19 Vaccines
- Chapter 14 Clinical Trials of COVID-19 Therapeutics and Vaccines History, Current Status, and Limitations
- Chapter 15 Lessons Learned from COVID-19 and Their Implementations for Future Pandemics
- Index
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app